McKelligon Brian 4
4 · Akoya Biosciences, Inc. · Filed Mar 4, 2025
Insider Transaction Report
Form 4
McKelligon Brian
DirectorPresident and CEO
Transactions
- Tax Payment
Common Stock
2025-03-01$1.63/sh−7,550$12,307→ 435,933 total - Tax Payment
Common Stock
2025-03-01$1.63/sh−8,257$13,459→ 427,676 total
Footnotes (2)
- [F1]Represents shares withheld to cover taxes on a restricted stock unit award previously granted on February 23, 2023, which vests in four (4) annual equal installments beginning on March 1, 2024 and annually thereafter until fully vested.
- [F2]Represents shares withheld to cover taxes on a restricted stock unit award previously granted on February 22, 2024, which vests in four (4) annual equal installments beginning on March 1, 2025 and annually thereafter until fully vested.